ActA has been shown to be capable of inhibiting BMP9 but not BMP2 and BMP4 signalling in two multiple myeloma cell lines [86], but such inhibition was not observed in endothelial cells [87]. This evidence concerns the gene ACTA1 and plasma cell myeloma.